Range
93.8 - 97.04
Vol / Avg.
628.6K/1.4M
Div / Yield
-
52 Wk
89.65 - 159.54
Mkt Cap
16.3B
Payout Ratio
-
Open
94.4
P/E
-
EPS
-1.03
Shares
171.9M
Outstanding
171.9M
Total Float
170.7M
load more
Sector: Health Care.Industry: Biotechnology
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in liquid biopsy (blood-based) cancer screening.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-02
REV
Q2 2021Est.ActualSurprise
EPS-0.760-1.030 -0.2700
REV421.280M434.819M13.539M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Exact Sciences Questions & Anwsers

Q

How do I buy Exact Sciences (EXAS) stock?

A

You can purchase shares of Exact Sciences (NASDAQ: EXAS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Exact Sciences's (EXAS) competitors?

Q

What is the target price for Exact Sciences (EXAS) stock?

A

The latest price target for Exact Sciences (NASDAQ: EXAS) was reported by Canaccord Genuity on July 29, 2021. The analyst firm set a price target for 160.00 expecting EXAS to rise to within 12 months (a possible 68.65% upside). 19 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Exact Sciences (EXAS)?

A

The stock price for Exact Sciences (NASDAQ: EXAS) is $94.87 last updated Tue Oct 26 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Exact Sciences (EXAS) pay a dividend?

A

There are no upcoming dividends for Exact Sciences.

Q

When is Exact Sciences (NASDAQ:EXAS) reporting earnings?

A

Exact Sciences’s $Q3 earnings are confirmed for after-market on $November 2, 2021.

Q

Is Exact Sciences (EXAS) going to split?

A

There is no upcoming split for Exact Sciences.

Q

What sector and industry does Exact Sciences (EXAS) operate in?

A

Exact Sciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.